Glen Harbor Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$470K Hold
9,196
0.01% 723
2019
Q2
$389K Hold
9,196
0.01% 788
2019
Q1
$454K Hold
9,196
0.01% 709
2018
Q4
$398K Hold
9,196
0.01% 704
2018
Q3
$522K Buy
9,196
+1,760
+24% +$92.6K 0.01% 706
2018
Q2
$375K Hold
7,436
0.01% 751
2018
Q1
$370K Hold
7,436
0.01% 748
2017
Q4
$306K Buy
7,436
+1,144
+18% +$40K 0.01% 825
2017
Q3
$187K Buy
6,292
+792
+14% +$24.2K ﹤0.01% 933
2017
Q2
$182K Buy
5,500
+2,486
+82% +$78.1K ﹤0.01% 885
2017
Q1
$89K Buy
+3,014
New +$82.3K ﹤0.01% 977

Other funds holding GMED

Glen Harbor Capital Management's GMED Position: Q3 2019 in Review

Glen Harbor Capital Management held its Globus Medical (GMED) position steady in Q3 2019 at 9,196 shares worth $470K. The position accounts for 0.01% of the portfolio, ranked #723.

Glen Harbor Capital Management first reported a position in GMED in Q1 2017 and has held it in 11 quarters since. The position peaked at $522K in Q3 2018. 268 funds tracked by Wall St. Rank hold GMED as of Q3 2019.

  • Glen Harbor Capital Management held 9,196 shares of Globus Medical worth $470K as of Q3 2019.
  • Glen Harbor Capital Management left its Globus Medical share count unchanged in Q3 2019.
  • Globus Medical made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #723 holding.
  • Glen Harbor Capital Management first reported a position in Globus Medical in Q1 2017 and has held it in 11 quarters since.
  • Glen Harbor Capital Management's Globus Medical position peaked at $522K in Q3 2018.
  • 268 funds tracked by Wall St. Rank held Globus Medical as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.